HilleVax Inc [NASDAQ: HLVX] slipped around 0.0 points on Friday, while shares priced at $1.86 at the close of the session, down 0.00%.
Compared to the average trading volume of 233.24K shares, HLVX reached a trading volume of 116357 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about HilleVax Inc [HLVX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HLVX shares is $2.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HLVX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Stifel have made an estimate for HilleVax Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 09, 2024. While these analysts kept the previous recommendation, Leerink Partners dropped their target price from $28 to $2. The new note on the price target was released on July 09, 2024, representing the official price target for HilleVax Inc stock. Previously, the target price had yet another drop from $28 to $2, while H.C. Wainwright kept a Neutral rating on HLVX stock. On July 08, 2024, analysts decreased their price target for HLVX shares from 24 to 5.
The Average True Range (ATR) for HilleVax Inc is set at 0.09 The Price to Book ratio for the last quarter was 0.62, with the Price to Cash per share for the same quarter was set at 3.18.
How has HLVX stock performed recently?
HilleVax Inc [HLVX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.58. With this latest performance, HLVX shares gained by 0.54% in over the last four-week period, additionally plugging by 2.20% over the last 6 months – not to mention a drop of -87.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HLVX stock in for the last two-week period is set at 49.64, with the RSI for the last a single of trading hit 44.19, and the three-weeks RSI is set at 51.62 for HilleVax Inc [HLVX]. The present Moving Average for the last 50 days of trading for this stock 1.7471, while it was recorded at 1.9180 for the last single week of trading, and 1.8330 for the last 200 days.
HilleVax Inc [HLVX]: Deeper insight into the fundamentals
HilleVax Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 25.32 and a Current Ratio set at 25.32.
Earnings analysis for HilleVax Inc [HLVX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HLVX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for HilleVax Inc go to 38.88%.
Insider trade positions for HilleVax Inc [HLVX]
There are presently around $70.80%, or 85.14%% of HLVX stock, in the hands of institutional investors. The top three institutional holders of HLVX stocks are: FRAZIER LIFE SCIENCES MANAGEMENT, L.P. with ownership of 10.62 million shares, which is approximately 21.9088%. TAKEDA PHARMACEUTICAL CO LTD, holding 6.72 million shares of the stock with an approximate value of $$97.23 million in HLVX stocks shares; and TAKEDA PHARMACEUTICAL CO LTD, currently with $$57.9 million in HLVX stock with ownership which is approximately 8.2629%.
